C12Y 101/01146
11-beta-hydroxysteroid dehydrogenase
Official title: 11-Beta-hydroxysteroid dehydrogenase (1.1.1.146)
C12Y101/01146 (11-beta-hydroxysteroid dehydrogenase) appears on 7 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 7
- Published applications
- 12
- Assignees
- 10
- Inventors
- 34
- Latest grant
- 16 Apr 2013
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 3 |
| 2006 | 0 | 1 |
| 2007 | 1 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 2 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 11βhydroxysteroid dehydrogenase type 116 Apr 2013US 8,420,365 B2Bristol-Myers Squibb Company
- Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases29 May 2012US 8,188,057 B2Sylentis S.A.U.
- Ghrelin variant protein3 Jan 2012US 8,088,730 B2
- Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression19 Oct 2010US 7,816,336 B2Isis Pharmaceuticals, Inc.
- Ghrelin variant protein13 Feb 2007US 7,176,292 B2Dialean, Ltd.
- Expanded metabolic pathway for androgen production by commensal bacteria25 Jun 2026US 2026/0177553 A1The Brd. of Trustees of the Univ. of Illinois
- Hepatocellular carcinoma treatments, prophylactic therapies, and compositions for use therewith7 Mar 2024US 2024/0075108 A1Repair Biotechnologies, Inc.
- Modulation of 11 beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases30 Jun 2011US 2011/0160277 A1Sylentis S.A.U.
- 11 beta hydroxysteroid dehydrogenase type 119 Aug 2010US 2010/0209990 A1Bristol-Myers Squibb Company
- Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes19 Apr 2007US 2007/0086997 A1
Most cited
By later US patents